Rick Pauls

President and CEO

CEO Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	DiaMedica Therapeutics Inc. (DMAC)	President and Chief Executive Officer	$645,000	—	—	$1,652,400	$412,500	$17,450	$2,727,350
2024	DiaMedica Therapeutics Inc. (DMAC)	President and Chief Executive Officer	$593,250	—	—	$633,510	$306,975	$17,250	$1,550,985
2023	DiaMedica Therapeutics Inc. (DMAC)	President and Chief Executive Officer	$562,000	—	—	$396,553	$239,958	$16,650	$1,215,161
2022	DiaMedica Therapeutics Inc. (DMAC)	President and Chief Executive Officer	$522,796	—	—	$343,819	$198,342	$15,650	$1,080,607
2021	DiaMedica Therapeutics Inc. (DMAC)	President and Chief Executive Officer	$477,448	—	—	$452,081	$191,590	$15,050	$1,136,169
2020	DiaMedica Therapeutics Inc. (DMAC)	President and Chief Executive Officer	$455,013	—	—	$190,624	$217,716	$14,850	$878,203
2019	DiaMedica Therapeutics Inc. (DMAC)	President and Chief Executive Officer	$420,000	—	—	$890,736	$178,000	$14,650	$733,707
2018	DiaMedica Therapeutics Inc. (DMAC)	President and Chief Executive Officer	$315,208	—	—	$241,304	$163,875	$13,320	$733,707

Executive changes

Appointed Director at DiaMedica Therapeutics Inc. (DMAC)
2024-05-22
Appointed Director at DiaMedica Therapeutics Inc. (DMAC)
2022-05-18

Earnings-call appearances

DiaMedica Therapeutics Inc. Q1 FY2026 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2026-05-07
DiaMedica Therapeutics Inc. Q1 FY2025 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2025-05-13
DiaMedica Therapeutics Inc. Q4 FY2024 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2025-03-17
DiaMedica Therapeutics Inc. Q3 FY2024 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2024-11-13
DiaMedica Therapeutics Inc. Q2 FY2024 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2024-08-07
DiaMedica Therapeutics Inc. Q3 FY2023 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2023-11-13
DiaMedica Therapeutics Inc. Q2 FY2023 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2023-08-14
DiaMedica Therapeutics Inc. Q1 FY2023 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2023-05-15
DiaMedica Therapeutics Inc. Q4 FY2022 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2023-03-28
DiaMedica Therapeutics Inc. Q2 FY2022 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2022-08-10
DiaMedica Therapeutics Inc. Q1 FY2022 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2022-05-04
DiaMedica Therapeutics Inc. Q4 FY2021 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2022-03-14
DiaMedica Therapeutics Inc. Q3 FY2021 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2021-11-10
DiaMedica Therapeutics Inc. Q2 FY2021 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2021-08-11
DiaMedica Therapeutics Inc. Q1 FY2021 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2021-05-05
DiaMedica Therapeutics Inc. Q4 FY2020 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2021-03-10
DiaMedica Therapeutics Inc. Q3 FY2020 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2020-11-04
DiaMedica Therapeutics Inc. Q2 FY2020 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2020-08-05
DiaMedica Therapeutics Inc. Q1 FY2020 Earnings Call
DiaMedica Therapeutics Inc. (DMAC)

2020-05-13